SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-013733
Filing Date
2021-07-12
Accepted
2021-07-12 11:13:07
Documents
16
Period of Report
2021-07-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20210706.htm   iXBRL 8-K 47209
2 EX-10.1 a101ex071221.htm EX-10.1 86081
3 EX-99.1 a991ex071221.htm EX-99.1 26874
7 crdf-20210706_g1.jpg GRAPHIC 176318
8 image_0.jpg GRAPHIC 50931
  Complete submission text file 0001628280-21-013733.txt   833434

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20210706.xsd EX-101.SCH 1935
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20210706_lab.xml EX-101.LAB 23970
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20210706_pre.xml EX-101.PRE 12660
9 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20210706_htm.xml XML 11057
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 211084817
SIC: 2836 Biological Products, (No Diagnostic Substances)